Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Lost it all

<< Previous

Bullboard Posts

Next >>

Comment by SS1316on Dec 02, 2022 11:21am

146 Views

Post# 35146448

RE:Lost it all

Firstly I sincerely hope your mention of being 'suicidal' is no more than dark humor, your life is of more value than any capital returns could ever amount to. I'm a professional FF myself, just a regular joe gettting beat down in the market this year and my position in THTX is down close to -30k but I intend to hold firm. This is not over IMO. Something about those 2 companies initiating coverage right before this news has me thinking there's more going on here than the short info we were just slapped in the mouth with...

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects